Ashfield provides clarity on the age old debate: ‘Syndicated’ or ‘Dedicated’ field sales?
pharmafile | July 28, 2016 | News story | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |
Ashfield is understandably well placed to offer a balanced viewpoint on field sales teams. With over 20 years of experience, Ashfield is a global contract services organisation that partners with pharma to provide dedicated commercial field teams, as well as being the first to introduce syndicated sales teams over 10 years ago.
Pharma has always had strong opinions on these competing commercial models and the debate still goes on in boardrooms across the globe. But perhaps the models aren’t competing at all? Maybe there’s a place for both in sales strategies, depending on brand, market place and objectives. Perhaps the first step in getting it right is to really get to grips with what each model involves, and the strengths of each.
Ashfield has drawn upon its experience in this sector and published an article that walks through both models in 5 simple steps. Covering topics including strategy, costs and implementation, the guide shows there really isn’t a ‘one size fits all approach’ to outsourcing a sales force.
Read Ashfield Commercial’s article in full here.






